Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
47.79 USD | +0.63% | -4.95% | -20.83% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.83% | 5.76B | |
-3.79% | 87.06B | |
+1.97% | 40.25B | |
-16.98% | 31.09B | |
+52.66% | 24.74B | |
-13.48% | 15.91B | |
-9.12% | 11.96B | |
-15.60% | 11.92B | |
-42.56% | 11.61B | |
+4.64% | 8.73B |
- Stock Market
- Equities
- APLS Stock
- News Apellis Pharmaceuticals, Inc.
- Apellis Pharmaceuticals : Wedbush Lifts Apellis Pharmaceuticals to Outperform From Neutral, Price Target to $71 From $48 on Pegcetacoplan Revenue Estimates